## Summary

The paper proposes CV-imputation, a cross-validation method for tuning parameter selection and model selection in graphon models. The key idea is to replace held-out validation edges with i.i.d. Bernoulli(θ) draws, then correct the resulting distribution shift via an affine transformation (Equation 6), avoiding the costly matrix-completion step required by prior edge-CV methods. The authors provide asymptotic theory (Theorem 1), simulations on four graphon models with four estimators, and real-data case studies including a COVID-19 drug-disease co-occurrence network.

## Strengths

1. **Perturbation-based imputation eliminates the low-rank assumption required by prior methods**: The method avoids the low-rank assumption on the probability matrix P that is critical for competing ECV (Li et al., 2020a). Table 1 shows CV-imputation handles full-rank graphs (Graphon 2) where ECV struggles (e.g., NS on Graphon 2: CV-imputation MSE 2.13 vs ECV 3.82).

2. **Asymptotic consistency guarantee (Theorem 1)**: The paper proves that the validation score V_K(M) is asymptotically parallel to the true loss L(M) up to a constant independent of M, so the minimizer of V_K approximately minimizes the true MSE. Condition 1's optimism bias is noted as computationally verifiable, bridging theory and practice.

3. **Consistent empirical superiority over ECV across all 16 estimator–graphon combinations (Table 1)**: CV-imputation selects models with lower MSE than ECV in all configurations (e.g., NS on Graphon 1: 0.51 vs 9.15; ICE on Graphon 2: 2.69 vs 3.05), averaged over 100 replications with standard deviations reported.

4. **Substantial computational speedups on real networks (Table 2)**: Wall-clock timings show 4.5× to 25× speedups over ECV on networks up to 2,617 nodes (PolBlog: 56.90s vs 258.65s; Yeast: 240.90s vs 6021.12s), consistent with the complexity analysis in Section 3.

5. **Model-agnostic design validated across diverse estimators**: The method works with NS, SAS, USVT, and ICE—estimators making very different structural assumptions—demonstrating the claimed model-agnostic property across fundamentally different estimation paradigms.

6. **Real-world validation via COVID-19 drug repurposing discovery**: The case study identifies ledipasvir as a candidate for treating COVID-19, corroborated by external clinical research (Pirzada et al., 2021) and a phase-3 clinical trial, providing independently verifiable evidence beyond synthetic benchmarks.

## Weaknesses

### Fatal
None.

### Major

1. **Overclaimed superiority over default selection (Table 1, line 155)**: The paper states "for all five estimation methods, our method and ECV select M resulting in lower MSE values compared to the default selection." This is factually incorrect for Graphon 3 with NS: default (0.74) has lower MSE than CV-imputation (0.79). Additionally, for Graphon 2 with NS, ECV (3.82) is worse than default (2.75). For Graphon 4 with NS, all three methods are essentially tied (1.05 vs 1.06 vs 1.06). The claim needs to be qualified to reflect the actual pattern—that CV-imputation generally beats or matches default but does not universally dominate it—rather than asserting uniform superiority.

2. **Inconsistent method count ("five" vs "four")**: Lines 155 and 182 refer repeatedly to "five estimation methods," but only four are listed (NS, SAS, USVT, ICE) in line 151 and evaluated in Table 1. This is a straightforward manuscript error that, combined with the overclaiming above, erodes confidence in the paper's preparation.

### Minor

3. **Number of folds K not reported for any experiment**: The paper describes a K-fold cross-validation procedure but never states what value of K was used in the simulations or case studies. This is a basic experimental design parameter that must be reported for reproducibility.

4. **100% model selection accuracy at n=200 reported without uncertainty measures (line 181)**: The claim of "100% accuracy rate in selecting the best candidate model" at n=200 is reported without standard errors, confidence intervals, or any measure of dispersion, even though results are averaged over 100 replications where some variance would be expected.

5. **Tuning parameter θ of the proposed method itself deferred to appendix**: The imputation mean θ is acknowledged as a tuning parameter (line 63) but its selection is deferred entirely to the appendix (Section S.4). Since CV-imputation is itself a method for tuning parameters, the fact that it introduces its own tuning parameter warrants at least a brief discussion of sensitivity or a default choice in the main text.

### Trivial

6. **Figure 3 caption text contradicts body text on speed**: The OCR-extracted figure caption (line 185/187) reads "In all cases, ECV is faster than CV-imputation," while the body text (line 173) and all other evidence (Table 2, complexity analysis) assert CV-imputation is faster. This is almost certainly a parser/OCR artifact from the embedded image caption, but it creates confusion and should be corrected.

## Nice-to-Haves

- Confidence intervals or error bars on the model selection accuracy results (Figure 5).
- A brief sensitivity analysis for the choice of θ in the main text, or at least stating the default value used.
- Clarifying whether Condition 1 is empirically verified for the specific graphon models and estimation methods used in the experiments (beyond the ER example).

## Removed Points

These points were raised by reviewers but are removed for the following reasons:

- **Figure 3 as a fatal structural contradiction**: The harsh critic flagged this as invalidating the computational efficiency contribution. However, every other piece of evidence in the paper (Table 2 showing 4.5× to 25× speedups, the complexity analysis in Section 3, body text at line 173, and conclusions at lines 237, 256) consistently supports CV-imputation being faster. The figure caption text is a parser/OCR artifact from the embedded image. Under the parser-error rule, this is removed as a fatal issue; it is retained as a trivial note about presentation.

- **Condition 1 not verified for specific models**: The harsh critic argued Condition 1 is not verified for the specific graphon models. However, the paper states it "can be verified computationally" and references Figure S.3 in the appendix for empirical validation. Since the appendix is stripped, this criticism is speculative.

- **"Model-agnostic" claim as oversold**: The paper explicitly states the method works under graphon models where edges are independent Bernoulli. The "model-agnostic" claim refers to being unbiased toward any specific estimator within this setting, which is standard terminology for cross-validation. No specific error was identified.

- **Generic evaluation rigor concerns about case study**: The claim that comparison between CV-imputation and ECV on the test set "conflates the quality of the tuning procedure with the quality of the resulting model's link prediction" is not concretely anchored to a specific error; the evaluation design is standard for comparing two tuning methods.

- **Strength Finder generic/superficial strengths about problem importance**: Removed as they provide no specific insight about the paper's contribution.

- **"Lack of tuning requirements" claim**: The harsh critic cited a sentence about "lack of tuning requirements" when the paper clearly discusses θ selection and K. The sentence in context likely refers to the method being user-friendly compared to ECV, not literally having zero parameters. This is a misreading.

## Novel Insights

The harsh critic's observation about the Table 1 overclaiming is the most valuable critical insight: it reveals a pattern where the paper's stated conclusions are slightly stronger than the data supports. Combined with the "five methods" inconsistency, this suggests the manuscript may have undergone revisions where some content changed without corresponding updates to summary claims. The Strength Finder's identification of the 16/16 ECV-beating record across all estimator–graphon combinations is notable because it confirms the method's superiority over the direct competitor is robust even while the comparison against default selection is more nuanced. The key takeaway is that CV-imputation clearly beats ECV and generally beats or matches default selection, but the paper would be stronger by acknowledging the few edge cases where default is competitive.

## Suggestions

1. **Correct the overclaim in line 155**: Replace "for all five estimation methods, our method and ECV select M resulting in lower MSE values compared to the default selection" with a qualified statement that acknowledges Graphon 3/NS as an exception and notes the pattern more accurately (e.g., "CV-imputation generally selects M resulting in lower or comparable MSE compared to default selection, with the most dramatic gains on dense graphons").

2. **Fix "five estimation methods" to "four estimation methods"** throughout the paper (lines 155, 182).

3. **Report the value of K** (number of folds) explicitly for all experiments in the main text.

4. **Add a brief note on how θ is set** in the main text (e.g., "we used θ = 0.5 throughout our experiments, and results were stable for θ ∈ [0.3, 0.7] as shown in Appendix S.4") rather than deferring entirely to the appendix.

5. **Add uncertainty measures** (standard errors or confidence intervals) to the 100% model selection accuracy claim.

6. **Fix the Figure 3 caption** to match the body text — if the figure indeed shows CV-imputation being faster, the caption should say so.

## Score and Decision

I cannot run the calibration tool due to a persistent data-path error. Proceeding with score assignment based on my own assessment.

The paper makes a real contribution: the CV-imputation idea is novel, well-motivated, theoretically supported, and empirically validated with strong results. The weaknesses are genuine but not fatal — they concern reporting accuracy (overclaimed default comparison, inconsistent method count, missing experimental details) rather than fundamental flaws in the method or evidence. These are all addressable in revision.

The paper's strengths (clean method, asymptotic theory, consistent ECV beating across 16 configurations, 4.5×-25× speedups, COVID-19 validation) substantially outweigh the weaknesses. I place this paper in the borderline-accept to accept range.

**MY FINAL SCORE: <score>6.0</score>**
**MY FINAL DECISION: <decision>Accept</decision>**